A Vascular Xenograft "KemAngioprotez"

KemAngioprotez1

   

The only blood vessel prosthesis in Russia derived from bovine internal thoracic artery and used for permanent arterial bed segments replacement.

It has been widely used in surgery since 1993.

 Обучение иконка_1 Training 
Статьи значок Articles
Значок видео_1 Video
Overview

KemAngioprotez Vascular Xenograft is designed for permanent arterial bed segments replacement.

KemAngioprotez is a part of bovine internal thoracic artery, treated with epoxy compound. Xenografts are manufactured from one, two or three arterial segments to obtain the required length.

Performance:
- vascular prostheses maintain their original flexibility and biomechanics: their robustness and resilience mimic those of native arteries due to diepoxy treatment;
- show significant enhancement of long-term permeability next to alloprostheses;
- extend both in an axial and lateral direction, feature sufficient strength, smoothed interface, are easily modelled and sutured;
- optimal balance between diameter, walls thickness and stress-strain performance with regard to anatomy facilitate the anastomosis between prostheses and recipients' arteries. Bioprostheses' walls are not prone to cutting and breaking when anastomosis is performed;
- KemAngioprotez arterial prosthesis clinical results are supported by evidence of diepoxy treatment efficiency with regard to structural and calcium-related deterioration risk mitigation.

Features of bioprostheses structural adaptation to recipients' arteries:
- enhanced bilogical compatibility of epoxy-treated xenogeneic materials with recipients' tissues;
- maintain convergence of native arteries, show no folding when an anastomosis is performed. When exposed to functional load they flex evenly, showing no rupture or hemodynamic gradient;
- additional heparin modification allows clot formation mitigation in anastomosis area.

Biological Tissue Treatment

Antithrombotic treatment:
(Article The new generation of heart valve bioprostheses with high thromboresistance and antibacterial activity)

- Vessel biological tissue antithrombotic treatment is performed with heparin. Test data has shown the best long-term permeability of bioprotheses featuring heparin modification.

Ordering Information

To place an order, please submit your requisition via email neocor@neocor.ru or use the website contact form.

You may consult our Sales Department for NeoCor medical devices by phone 9 AM to 5 PM (Moscow time +4) on business days.

No

Length, mm (±5.0)

Distal diameter, mm (±0.25)

 Proximal diameter, mm (±0.5)

Reference No

1

100

3.0

4.0

БПКС100

2

200

4.0

6.0

БПКС200

3

300

4.0

6.0

БПКС300

4

400

3.5

6.5

БПКС400

5

500

3.0

6.5

БПКС500

6

600

3.0

6.5

БПКС600

7

650*

Custom-made (3.0/6.5)

БПКС650

8

700*

Custom-made (3.0/6.5)

БПКС700

9

750*

Custom-made (3.0/6.5)

БПКС750

      * - As per part 5, Article 38 of the Federal Law No 323-FZ «On Fundamental Healthcare Principles in the Russian Federation» dated November 21, 2011, paragraph 2, clause 2 of the Russian Federation Government Resolution No1416 dated December 27, 2012 «On Approval of the Rules for State Registration of medical devices» KemAngioprotez vascular prosthesis longer then 600 mm can only be custom made by medical prescription and intented for exclusive use in a certain patient.

 

KemAngio (new data)

 

 

 

CJSC NeoCor, OGRN 1024200695991, address: 6 Sosnovy boulevard, Kemerovo, 650002, Russia